Next Generation CAR & T Cell Therapies
The upcoming conference on CAR and T Cell Therapies in San Francisco, USA on June 18-20, 2019 will focus on innovative manufacturing and commercialization strategies in the highly competitive field of CAR T cell therapy. It will be held under the headline: “Revolutionizing cell engineering – ground breaking autologous and allogeneic treatments for blood borne and solid tumors”.
Topics will include discussions on alternatives for CD19, cover the area of allogeneic feasibility, automation, scalability and vector bottlenecks and also get into the field of quality monitoring.
More information on the conference is available here.